Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
2012
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
2006
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
2009 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
The implications of angiogenesis for the biology and therapy of cancer metastasis
1994 Standout
The risk of venous thromboembolism is increased throughout the course of malignant glioma
2000
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
2012
IDH1andIDH2Mutations in Gliomas
2009 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Hypocomplementemia Discloses Genetic Predisposition to Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura
1999
Intestinal Electrolyte Transport and Diarrheal Disease
1989
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Advances in Radiation Therapy for Brain Tumors
2007
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Photodynamic therapy of high grade glioma – long term survival
2005
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
The ErbB receptor family: a therapeutic target for cancer
2002
Glioblastoma and Other Malignant Gliomas
2013 Standout
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial
2005
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Thromboembolic disease in patients with high-grade glioma
2012
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Prevalence and outcomes of anemia in surgery: a systematic review of the literature
2004
Survival rates in patients with low‐grade glioma after intraoperative magnetic resonance image guidance
2005
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
2008
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
2008 Standout
Anticancer therapy targeting the erbB family of receptor tyrosine kinases
2001
EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW-GRADE GLIOMAS
2008
Tyrosine kinases as targets in cancer therapy – successes and failures
2003
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTTCNS Consortium study
2004
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Anaplastic Oligodendroglioma and Oligoastrocytoma
2007
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Malignant Gliomas in Adults
2008 Standout
Prevention of Venous Thromboembolism
2004 Standout
Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines
2010
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Erlotinib (Tarceva®): a promising drug targeting epidermal growth factor receptor tyrosine kinase
2003
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
2006
Complement
2001 Standout
Prevalence and outcomes of anemia in cancer: a systematic review of the literature
2004
Photodynamic therapy of cancer: An update
2011 Standout
Primary brain tumours in adults
2003
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment
2003
Primary brain tumours in adults
2012 Standout
Radiation Dose–Volume Effects in the Heart
2010
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
HLA‐DR53 protects against thrombotic thrombocytopenic purpura/adult hemolytic uremic syndrome
1994
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
The densely fluorinated nanospace of a porous coordination polymer composed of perfluorobutyl-functionalized ligands
2014 StandoutNobel
Role of Radiation Therapy and Radiosurgery in Glioblastoma Multiforme
2003
Strategies used in coping with a cancer diagnosis predict meaning in life for survivors.
2006
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
A restricted cell population propagates glioblastoma growth after chemotherapy
2012 StandoutNature
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
2011
Anemia of Chronic Disease
2005 Standout
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Making sense of the meaning literature: An integrative review of meaning making and its effects on adjustment to stressful life events.
2010 Standout
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
2005 Standout
Erythropoietin, iron, and erythropoiesis
2000
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Is Generally Well-Tolerated and Has Activity in Non–Small-Cell Lung Cancer and Other Solid Tumors: Results of a Phase I Trial
2002
Cutaneous Adverse Effects With HER1/EGFR-Targeted Agents: Is There a Silver Lining?
2005
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
2004 Standout
A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.
2001
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma
2003
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities
2003
Oxygen Carriers (“Blood Substitutes”)Raison d'Etre, Chemistry, and Some PhysiologyBlut ist ein ganz besondrer Saft
2001
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
2007
Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
2006
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
2007 Standout
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
2008 Standout
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
2008
Erythropoietin, iron, and erythropoiesis.
2000
The biology of cancer metastasis and implications for therapy
1987
Erythropoietin, iron, and erythropoiesis
2000
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma
2002
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Thromboembolism in Hospitalized Neutropenic Cancer Patients
2006
Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions
2004
Selected Novel Anticancer Treatments Targeting Cell Signaling Proteins
2001
Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination
2003
Works of Richard Hellman being referenced
Stage II breast cancer: Differences between four coping patterns in side effects during adjuvant chemotherapy
1997
A Phase II Study of Preradiation Chemotherapy Followed by External Beam Radiotherapy for the Treatment of Patients with Newly Diagnosed Glioblastoma Multiforme: An Eastern Cooperative Oncology Group Study (E2393)
2000
Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: A randomized, double-blind, controlled trial of recombinant human erythropoietin
1996
The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double‐blind, controlled trial
1996
Venous Thromboembolism and High Grade Gliomas
1993
Trifluoperazine Reversal of Secretory Diarrhea in Pancreatic Cholera
1980
Phase III Study Comparing Three Cycles of Infusional Carmustine and Cisplatin Followed by Radiation Therapy With Radiation Therapy and Concurrent Carmustine in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme: Eastern Cooperative Oncology Group Trial 2394
2003
Prospective Randomized Trial of Low- Versus High-Dose Radiation Therapy in Adults With Supratentorial Low-Grade Glioma: Initial Report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study
2002
A phase I dose escalation study of epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitor CP-358,774 in patients (pts) with advanced solid tumors
2000
The human tumor colony-forming chemosensitivity assay: A biological and clinical review
1984